 | Kohli M, Ham L, Saloner R, Dung D, Iudicello J Ellis RJ, Moore DJ. (2024). Latent profile analysis of cognitive performance and depressive symptoms among people with HIV. AIDS Patient Care And STDs, 38(2), 93-106. PMID: 38381950 PMCID: 10890962 | | Watson CW-M, Sundermann E, Helm J, Paolillo EW, Hong S, Ellis RJ, Letendre S, Marcotte TD, Heaton RK, Morgan EE, Grant I. (2023). A longitudinal study of cannabis use and risk for cognitive and functional decline among older adults with HIV. AIDS and Behavior, 27(10), 3401-3413. PMID: 37155086 | | Sundermann EE, Campbell LM, Villers O, Bondi MW, Gouaux B, Salmon DP, Galasko D, Soontornniyomkij V, Ellis RJ, Moore DJ. (2023). Alzheimer's Disease pathology in middle aged and older people with HIV: Comparisons with non-HIV controls on a healthy aging and Alzheimer's Disease trajectory and relationships with cognitive function. Viruses, 15(6), 1319. PMID: 37376619 PMCID: 10305373 | | Riggs PK, Anderson AM, Tang B, Rubin LH, Morgello S, Marra CM, Gelman BB, Clifford DB, Franklin D, Heaton RK, Ellis RJ, Fennema-Notestine C, Letendre SL. (2023). Elevated plasma protein carbonyl concentration is associated with more abnormal white matter in people with HIV. Viruses, 15(12), 2410. PMID: 38140650 PMCID: 10747698 | | Sundermann EE, Dastgheyb R, Moore DJ, Buchholz AS, Bondi MW, Ellis RJ, Letendre SL, Heaton RK, Rubin LH. (2023). Identifying and distinguishing cognitive profiles among virally suppressed people with HIV. Neuropsychology, Epub Nov 16. PMID: 37971860 | | Tavasoli A, Gelman BB, Marra CM, Clifford DB, Iudicello JE, Rubin LH, Letendre SL, Tang B, Ellis RJ. (2023). Increasing neuroinflammation relates to increasing neurodegeneration in people with HIV. Viruses, 15(9), 1835. PMID: 37766242 PMCID: 10536802 | | Volpe KE, Samuels DC, Elson JL, Steyn JS, Gebretsadik T, Ellis RJ, Heaton RK, Kallianpur AR, Letendre S, Hulgan T. (2023). Mitochondrial DNA mutation pathogenicity score and neurocognitive performance in persons with HIV. Mitochondrion, Epub Nov 19. PMID: 37989461 | | Petersen KJ, Yu X, Masters MC, Lobo JD, Lu T, Letendre S, Ellis RJ, McCutchan JA, Sundermann E. (2023). Sex-specific associations between plasma interleukin-6 and depression in persons with and without HIV. Brain, Behavior, & Immunity - Health, 30, 100644. PMID: 37347049 PMCID: 10279778 | | Fisher A, Moore DJ, Levine AJ, Masliah E Gouaux B, Soontornniyomkij V, Letendre S, Sundermann EE. (2023). The relationship between synaptodendritic neuropathology and HIV-associated neurocognitive disorders is moderated by cognitive reserve. Journal of Neurovirology, Epub Nov 9. PMID: 37943478 | | Kakarla V, Letendre SL, Ellis RJ. (2023). Time of day influences concentrations of total protein and albumin in cerebrospinal fluid in HIV. International Journal of Molecular Sciences, 24(3), 2832. PMID: 36769155 PMCID: PMC9917345 | | Heaton RK, Ellis RJ, Tang B, Marra CM, Rubin LH, Clifford DB, McCutchan JA, Gelman BB, Morgello S, Franklin DR, Letendre SL. (2023). Twelve-year neurocognitive decline in HIV is associated with comorbidities, not age: a CHARTER Study. Brain, 146(3), 1121-1131. PMID: 36477867 PMCID: 10169412 | | Bai H, Kaur H, Kallianpur AR, Hulgan T, Franklin DR, Letendre SL, Ellis R, Bush WS. (2022). A haptoglobin exon copy number variant associates with HIV-associated neurocognitive impairment in European and African-descent populations. Frontiers in Genetics, 12, 756685. PMID: 35003209 PMCID: PMC8727522 | | Deme P, Moniruzzaman M, Moore D, Heaton R, Ellis R, Letendre S, Haughey N. (2022). Association of plasma eicosanoid levels with immune, viral, and cognitive outcomes in people with HIV. Neurology, Epub Jul 18. PMID: 35851253 | | Saloner R, Lobo JD, Paolillo EW, Campbell LM, Letendre SL, Cherner M, Grant I, Heaton RK, Ellis RJ, Moore DJ. (2022). Cognitive and physiologic reserve independently relate to superior neurocognitive abilities in adults aging with HIV. Journal of Acquired Immune Deficiency Syndromes, 90(4), 440-448. PMID: 35364601 PMCID: PMC9246889 | | Lobo JD, Moore DJ, Bondi MW, Soontornniyomkij V, Soontornniyomkij B, Gouaux B, Achim CL, Ellis RJ, Sundermann EE. (2022). CSF markers of AD-related pathology relate specifically to memory impairment in older people with HIV: a pilot study. Journal of Neurovirology, 28(1), 162-167. PMID: 35103880 PMCID: PMC9081235 | | Watson C W-M, Kamalyan L, Tang B, Hussain MA, Cherner M, Mindt MR, Byrd DA, Franklin DR, Collier AC, Clifford DB, Gelman B, Morgello S, McCutchan JA, Ellis RJ, Grant I, Heaton RK, Marquine MJ. (2022). Ethnic/racial disparities in longitudinal neurocognitive decline in people with HIV. Journal of Acquired Immune Deficiency Syndromes, 90(1), 97-105. PMID: 35081558 PMCID: PMC8986565 | | Solanky D, Fields JA, Iudicello JE, Ellis RJ, Franklin D, Clifford DB, Gelman BB, Marra CM, Morgello S, Rubin LH, Grant I, Heaton RK, Letendre SL, Mehta SR. (2022). Higher buccal mitochondrial DNA and mitochondrial common deletion number are associated with markers of neurodegeneration and inflammation in cerebrospinal fluid. Journal of Neurovirology, 28(2), 281-290. PMID: 35157246 PMCID: PMC9352370 | | Saloner R, Lobo JD, Paolillo EW, Campbell LM, Letendre SL, Cherner M, Grant I, Heaton RK, Ellis RJ, Roesch SC, Moore DJ, CHARTER Study Group. (2022). Identification of youthful neurocognitive trajectories in adults aging with HIV: A latent growth mixture model. AIDS And Behavior, 26(6), 1966-1979. PMID: 34878634 PMCID: PMC9046348 | | Ellis RJ, Sacktor N, Clifford DB, Marra CM, Collier AC, Gelman B, Robinson-Papp J, Letendre SL, Heaton RK. (2022). Neuropathic pain correlates with worsening cognition in people with human immunodeficiency virus. Brain, 145(6), 2206-2213. PMID: 35773234 | | Ellis RJ, Heaton RK, Tang B, Collier AC, Marra CM, Gelman BB, Morgello S, Clifford DB, Sacktor N, Cookson D, Letendre S. (2022). Peripheral inflammation and depressed mood independently predict neurocognitive worsening over 12 years. Brain, Behavior, & Immunity - Health, 21, 100437. PMID: 35308084 PMCID: PMC8928134 | | Sundermann EE, Saloner R, Rubtsova A, Nguyen AL, Letendre S, Moore RC, Cherner M, Ma Q, Marquine MJ. (2022). The association between benzodiazepine use and greater risk of neurocognitive impairment is moderated by medical burden in people with HIV. Journal of Neurovirology, 28(3), 410-421. PMID: 35389174 PMCID: PMC9470605 | | Rourke SB, Bekele Tsegaye, Rachlis Anita, Kovacs Colin, Brunetta Jason, Gill M John, Carvalhal Adriana, Cysique Lucette A, Marcotte Thomas, Power Christopher. (2021). Asymptomatic neurocognitive impairment is a risk for cymptomatic decline in a large HIV Canadian cohort study. AIDS, 35(1), 63-72. PMID: 33048883 | | Saloner R, Paolillo EW, Heaton RK, Grelotti DJ, Stein MB, Miller AH, Atkinson JH, Letendre SL, Ellis RJ, Grant I, Iudicello JE, Moore DJ. (2021). Chronically elevated depressive symptoms interact with acute increases in inflammation to predict worse neurocognition among people with HIV. Journal of Neurovirology, 27(1), 160-167. PMID: 33405198 | | Nguyen AL, Sundermann E, Rubtsova AA, Sabbag S Umlauf A, Heaton R Letendre S, Jeste DV, Marquine MJ. (2021). Emotional health outcomes are influenced by sexual minority identity and HIV serostatus. AIDS Care, 33(9), 1127-1132. PMID: 32590909 PMCID: PMC7762728 | | Kaur H, Bush WS, Letendre SL, Ellis RJ, Heaton RK, Patton SM, Connor JR, Samuels DC, Franklin DR, Hulgan T, Kallianpur AR. (2021). Higher CSF ferritin heavy-chain (Fth1) and transferrin predict better neurocognitive performance in people with HIV. Molecular Neurobiology, 58(10), 4842-4855. PMID: 34195939 | | Volpe K, Samuels D, Kallianpur A, Ellis R, Franklin D, Letendre S, Heaton RK, Hulgan T. (2021). Mitochondrial DNA haplogroups and domain-specific neurocognitive performance in adults with HIV. Journal of Neurovirology, 27(4), 557-567. PMID: 34101088 | | Lorenz DR, Mukerji SS, Misra V, Uno H, Gelman BB, Moore J, Singer EJ, Morgello S, Gabuzda D. (2021). Multimorbidity networks associated with frailty among middle aged and older people with HIV. AIDS (London, England), 35(15), 2451-2461. PMID: 34324449 PMCID: PMC8649075 | | Diaz MM, Keltner JR, Simmons AN, Franklin D, Moore RC, Clifford D, Collier AC, Gelman BB, Marra C, McCutchan JA, Morgello S, Sacktor N, Best B, Notestine CF, Weibel SG, Grant I, Marcotte TD, Vaida F, Letendre S, Heaton R, Ellis RJ. (2021). Paresthesia predicts increased risk of distal neuropathic pain in older people with HIV-associated sensory polyneuropathy. Pain Medicine, 22(8), 1850-1856. PMID: 33565583 PMCID: PMC8502467 | | Cysique LA, Casaletto KB, Heaton RK. (2021). Reliably measuring cognitive change in the era of chronic HIV infection and chronic HIV-associated neurocognitive disorders. Current Topics in Behavioral Neurosciences, 50, 271-298. PMID: 31559600 | | Sundermann EE, Fields A, Saloner R, Gouaux B, Bharti A, Murphy C, Moore DJ. (2021). The utility of olfactory function in distinguishing early stage Alzheimer's disease from HIV-associated neurocognitive disorder. AIDS, 35(3), 429-437. PMID: 33252483 | | May PE, Heithoff AJ, Wichman CS, Phatak VS, Moore DJ, Heaton RK, Fox HS. (2020). Assessing cognitive functioning in people living with HIV (PLWH): Factor analytic results from CHARTER and NNTC cohorts. Journal of Acquired Immune Deficiency Syndromes, 83(3), 251-259. PMID: 31913991 PMCID: PMC7051833 | | Sundermann EE, Bondi MW, Campbell LM, Gouaux B, Moore RC, Soontornniyomkij V, Moore DJ. (2020). Distinguishing amnestic mild cognitive impairment from HIV-associated neurocognitive disorders. The Journal of Infectious Diseases, 224(3), 435-442. PMID: 33319235 | | Keltner JR, Tong A, Visser E, Jenkinson M, Connolly CG, Dasca A, Sheringov A, Calvo Z, Umbao E, Mande R, Bilder MB, Sahota G, Franklin DR, Corkran S, Grant I, Archibald S, Vaida F, Brown GG, Atkinson JH, Simmons AN, Ellis RJ. (2020). Evidence for a novel subcortical mechanism for posterior cingulate cortex atrophy in HIV peripheral neuropathy. Journal of Neurovirology, 26(4), 530-543. PMID: 32524422 PMCID: PMC7442648 | | Ellis RJ, Letendre SL, Atkinson JH, Clifford D, Collier AC, Gelman BB, Marra C, McCutchan JA, Morgello S, Sacktor N, Tang B, Heaton RK. (2020). Higher levels of plasma inflammation biomarkers are associated with depressed mood and quality of life in aging, virally suppressed men, but not women, with HIV. Brain, Behavior, & Immunity - Health, 7, 100121. PMID: 34589877 PMCID: PMC8474567 | | Fennema-Notestine C, Thornton-Wells TA, Hulgan T, Letendre S, Ellis RJ, Franklin DR, Anderson AM, Heaton RK, Bloss CS, Grant I, Kallianpur AR. (2020). Iron-regulatory genes are associated with neuroimaging measures in HIV infection. Brain Imaging And Behavior, 14(5), 2037-2049. PMID: 31273671 PMCID: PMC6940558 | | Ellis RJ, Moore DJ, Sundermann EE, Heaton RK, Mehta S, Hulgan T, Samuels D, Fields JA, Letendre SL. (2020). Nucleic acid oxidation is associated with biomarkers of neurodegeneration in CSF in people with HIV. Neurology, Neuroimmunology & Neuroinflammation, 7(6), e902. PMID: 33055205 PMCID: PMC7577534 | | Ellis RJ, Diaz M, Sacktor N, Marra C, Collier AC, Clifford DB, Calcutt N, Fields JA, Heaton RK, Letendre SL, Franklin D, Best B, Cookson D, Cushman C, Dawson M, Fennema CN, Weibel SG, Grant I, Marcotte TD, Marquie-Beck J, Vaida F, Rogalski V, Morgello S Mintz L, McCutchan JA, Storey S, Gelman B, Head E, Teshome M. (2020). Predictors of worsening neuropathy and neuropathic pain after 12 years in people with HIV. Annals of Clinical And Translational Neurology, 7(7), 1166-1173. PMID: 32619341 PMCID: PMC7359117 | | Saloner R, Grelotti DJ, Tyree G, Sundermann EE, Ma Q, Letendre S, Heaton RK, Cherner M. (2019). Benzodiazepine use is associated with an increased risk of neurocognitive impairment in people living with HIV. Journal of Acquired Immune Deficiency Syndromes (1999), 82(5), 475-482. PMID: 31714426 PMCID: PMC6857713 | | Xu J, Umlauf A, Letendre S, Franklin D, Bush WS, Atkinson JH, Keltner J, Ellis RJ. (2019). Catechol-O-methyltransferase polymorphism Val158Met is associated with distal neuropathic pain in HIV-associated sensory neuropathy. AIDS (London, England), 33(10), 1575-1582. PMID: 31021849 PMCID: PMC7380251 | | Kallianpur AR, Gittleman H, Letendre S, Ellis R, Barnholtz-Sloan JS, Bush WS,
Heaton R, Samuels DC, Franklin DR Jr, Rosario-Cookson D, Clifford DB, Collier AC,
Gelman B, Marra CM, McArthur JC, McCutchan JA, Morgello S, Grant I, Simpson D,
Connor JR, Hulgan T; CHARTER Study Group. (2019). Cerebrospinal Fluid Ceruloplasmin,
Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with
Neurocognitive Impairment in Adults with HIV Infection. Molecular Neurobiology, 56(5), 3808-3818. PMID: 30209774 PMCID: PMC6952215 | | Perez-Valero I, Ellis R, Heaton R, Deutsch R, Franklin D, Clifford DB, Collier A, Gelman B, Marra C, McCutchan JA, Navis A, Sacktor N, Simpson D, Grant I, Letendre S. (2019). Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects. AIDS, 33(3), 475-481. PMID: 30702516 PMCID: PMC6361539 | | Sakabumi DZ, Moore RC, Tang B, Delaney PA, Keltner JR, Ellis RJ. (2019). Chronic distal sensory polyneuropathy is a major contributor to balance disturbances in persons living with HIV. Journal of Acquired Immune Deficiency Syndromes (1999), 80(5), 568-573. PMID: 30649035 | | Dastgheyb RM, Sacktor N, Franklin D, Letendre S, Marcotte T, Heaton R, Grant I, McArthur J, Rubin LH, Haughey NJ. (2019). Cognitive trajectory phenotypes in human immunodeficiency virus infected patients. Journal of Acquired Immune Deficiency Syndromes, 82(1), 61-70. PMID: 31107302 PMCID: PMC6692206 | | Saloner R, Marquine MJ, Sundermann EE, Hong S, McCutchan JA, Ellis RJ, Heaton RK, Grant I, Cherner M. (2019). COMT Val158Met polymorphism, cardiometabolic risk, and nadir CD4 synergistically increase risk for neurocognitive impairment in men living with HIV. Journal of Acquired Immune Deficiency Syndromes, 81(5), e148-e157. PMID: 31107306 | | Livelli A, Vaida F, Ellis RJ, Ma Q, Ferrara M, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, McCutchan JA, Morgello S, Sacktor N, Simpson DM, Grant I, Letendre SL; CHARTER Group. (2019). Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort study. The Lancet HIV, 6(7), e456-e462. PMID: 31208949 | | Saloner R, Heaton RK, Campbell LM, Chen A, Franklin D, Ellis RJ, Collier AC, Marra C, Clifford DB, Gelman B, Sacktor N, Morgello S, Mccutchan JA, Letendre S, Grant I, Fennema-Notestine C. (2019). Effects of comorbidity burden and age on brain integrity in HIV. AIDS (London, England), 33(7), 1175-1185. PMID: 30870195 | | Khuder SS, Chen S, Letendre S, Marcotte T, Grant I, Franklin D, Rubin LH, Margolick JB, Jacobson LP, Sacktor N, D'Souza G, Stosor V, Lake JE, Rapocciolo G, McArthur J, Dickens A, Haughey N. (2019). Impaired insulin sensitivity is associated with worsening cognition in HIV-infected patients. Neurology, 92(12), e1344-e1353. PMID: 30787163 PMCID: PMC6511093 | | Sundermann EE, Hussain MA, Moore DJ, Horvath S, Lin DTS, Kobor MS, Levine A. (2019). Inflammation-related genes are associated with epigenetic aging in HIV. Journal of Neurovirology, 25(6), 853-865. PMID: 31286441 PMCID: PMC6923602 | | Saloner R, Campbell LM, Serrano V, Montoya JL, Pasipanodya E, Paolillo EW, Franklin D, Ellis RJ, Letendre SL, Collier AC, Clifford DB, Gelman BB, Marra CM, McCutchan JA, Morgello S, Sacktor N, Jeste DV, Grant I, Heaton RK, Moore DJ. (2019). Neurocognitive SuperAging in older adults living with HIV: Demographic, neuromedical and everyday functioning correlates. Journal of The International Neuropsychological Society : JINS, 25(5), 507-519. PMID: 30890191 | | Hulgan T, Kallianpur AR, Guo Y, Barnholtz-Sloan JS, Gittleman H, Brown TT, Ellis R, Letendre S, Heaton RK, Samuels DC. (2019). Peripheral blood mitochondrial DNA copy number obtained from genome-wide genotype data is associated with neurocognitive impairment in persons with chronic HIV infection. Journal of Acquired Immune Deficiency Syndromes (1999), 80(4), e95-e102. PMID: 30531306 PMCID: PMC6391216 | | Gianella S, Letendre SL, Iudicello J, Franklin D, Gaufin T, Zhang Y, Porrachia M, Vargas-Meneses M, Ellis RJ, Finkelman M, Hoenigl M. (2019). Plasma (1-3)-Beta-D-glucan and suPAR levels correlate with neurocognitive performance in people living with HIV on antiretroviral therapy: a CHARTER analysis. Journal of Neurovirology, 25(6), 837-843. PMID: 31297727 PMCID: PMC6923595 | | Alakkas A, Ellis RJ, Watson CW, Umlauf A, Heaton RK, Letendre S, Collier A, Marra C, Clifford DB, Gelman B, Sacktor N, Morgello S, Simpson D, McCutchan JA, Kallianpur A, Gianella S, Marcotte T, Grant I, Fennema-Notestine C, and the CHARTER Group. (2019). White matter damage, neuroinflammation, and neuronal integrity in HAND. Journal of Neurovirology, 1, 32-41. PMID: 30291567 PMCID: PMC6416232 | | Marquine MJ, Heaton A, Johnson N, Rivera-Mindt M, Cherner M, Bloss C, Hulgan T, Umlauf A, Moore DJ, Fazeli P, Morgello S, Franklin D, Letendre S, Ellis R, Collier AC, Marra CM, Clifford DB, Gelman BB, Sacktor N, Simpson D, McCutchan JA, Grant I, Heaton RK. (2018). Differences in neurocognitive impairment among HIV-infected Latinos in the United States. Journal of The International Neuropsychological Society : JINS, 24(2), 163-175. PMID: 28874213 PMCID: PMC5777885 | | Patton SM, Wang Q, Hulgan T, Connor JR, Jia P, Zhao Z, Letendre SL, Ellis RJ, Bush WS, Samuels DC, Franklin DR, Kaur H, Iudicello J, Grant I, Kallianpur AR. (2017). Cerebrospinal fluid (CSF) biomarkers of iron status are associated with CSF viral load, antiretroviral therapy, and demographic factors in HIV-infected adults. Fluids And Barriers of The CNS, 14(1), 11. PMID: 28427421 PMCID: PMC5399327 | | Mehta S, Perez-Santiago J, Hulgan T, Day T, Barnholtz-Sloan J, Gittleman H, Letendre S, Ellis R, Heaton R, Patton S, Suben J, Franklin D, Rosario D, Clifford D, Collier A, Marra C, Gelman B, McArthur J, McCutchan A, Morgello S, Simpson D, Connor J, Grant I, Kallianpur A. (2017). Cerebrospinal fluid cell-free mitochondrial DNA is associated with HIV replication, iron transport, and mild HIV-associated neurocognitive impairment. Journal of Neuroinflammation, 14(1), 72. PMID: 28359324 | | Samuels DC, Kallianpur A, Ellis R, Bush W, Letendre S, Franklin D, Grant I, Hulgan T. (2017). European mitochondrial DNA haplogroups are associated with cerebrospinal fluid biomarkers of inflammation in HIV infection. Pathogens & Immunity, 1(2), 330-351. PMID: 28317034 PMCID: PMC5351881 | | Obermeit LC, Beltran J, Casaletto KB, Franklin DR, Letendre S, Ellis R, Fennema-Notestine C, Vaida F, Collier AC, Marra CM, Clifford D, Gelman B, Sacktor N, Morgello S, Simpson D, McCutchan JA, Grant I, Heaton RK. (2017). Evaluating the accuracy of self-report for the diagnosis of HIV-associated neurocognitive disorder (HAND): Defining "symptomatic" versus "asymptomatic" HAND. Journal of Neurovirology, 23(1), 67-78. PMID: 27557777 PMCID: PMC5325815 | | Jia P, Zhao Z, Hulgan T, Bush WS, Samuels DC, Bloss CS, Heaton RK, Ellis RJ, Schork N, Marra CM, Collier AC, Clifford DB, Gelman BB, Sacktor N, Morgello S, Simpson DM, McCutchan JA, Barnholtz-Sloan JS, Franklin DR, Rosario D, Letendre SL, Grant I, Kallianpur AR. (2017). Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER Group study. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : The Official Publication of The International Society of Psychiatric Genetics, 174(4), 413-426. PMID: 28447399 PMCID: PMC5435520 | | Keltner JR, Connolly CG, Vaida F, Jenkinson M, Fennema-Notestine C, Archibald S, Akkari C, Schlein A, Lee J, Wang D, Kim S, Li H, Rennels A, Miller DJ, Kesidis G, Franklin DR, Sanders C, Corkran S, Grant I, Brown GG, Atkinson JH, Ellis RJ. (2017). HIV distal neuropathic pain is associated with smaller ventral posterior cingulate cortex. Pain Medicine, 18(3), 428-440. PMID: 27497320 | | Christensen B, Qin Z, Byrd DA, Yu F, Morgello S, Gelman BB, Moore DJ, Grant I, Singer EJ, Fox H, Baccaglini L. (2017). Measures of physical and mental independence among HIV-positive individuals: Impact of substance use disorder. AIDS Research And Human Retroviruses, 33(10), 1048-1055. PMID: 28288515 PMCID: PMC5650716 | | Anderson AM, Munoz-Moreno JA, McClernon D, Ellis RJ, Cookson D, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, McCutchan JA, Morgello S, Sacktor N, Simpson DM, Franklin DR, Heaton RK, Grant I, Letendre SL. (2017). Prevalence and correlates of persistent HIV-1 RNA in cerebrospinal fluid during antiretroviral therapy. The Journal of Infectious Diseases, 215(1), 105-113. PMID: 27789723 PMCID: PMC5225254 | | Anderson A, Schein T, Kalapila A, Lai L, Waldrop-Valverde D, Moore R, Franklin D, Letendre S, Barnum S. (2017). Soluble membrane attack complex in the blood and cerebrospinal fluid of HIV-infected individuals, relationship to HIV RNA, and comparison with HIV negatives. Journal of Neuroimmunology, 311, 35-39. PMID: 28774464 | | Kallianpur AR, Wang Q, Jia P, Hulgan T, Zhao Z, Letendre SL, Ellis RJ, Heaton RK, Franklin DR, Barnholtz-Sloan J, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan J A, Grant Igor. (2016). Anemia and red cell indices predict HIV-associated neurocognitive impairment in the HAART Era. The Journal of Infectious Diseases, 213(7), 1065-1073. PMID: 26690344 PMCID: PMC4779306 | | Cooley S, Paul R, Fennema-Notestine C, Morgan E, Vaida F, Deng Q, Chen J, Letendre S, Ellis R, Clifford D, Marra C, Collier A, Gelman B, McArthur J, McCutchan JA, Simpson D, Morgello S, Grant I, Ances B. (2016). Apolipoprotein E ε4 genotype status is not associated with neuroimaging outcomes in a large cohort of HIV+ individuals. Journal of Neurovirology, 22(5), 607-614. PMID: 27021072 PMCID: PMC5040614 | | Joseph J, Cinque P, Colosi D, Dravid A, Ene L, Fox H, Gabuzda D, Gisslen M, Beth J, Letendre S, Mukerji SS, Nath A, Perez-Valero I, Persaud D, Price RW, Rao VR, Sacktor N, Swanstrom R, Winston A, Wojna V, Wright E, Spudich S. (2016). Highlights of the global HIV-1 CSF Escape Consortium Meeting, 9 June 2016, Bethesda, MD, USA. Journal of Virus Eradication, 2(4), 243-250. PMID: 27781109 PMCID: PMC5075354 | | Brouillette M, Yuen T, Fellows LK, Cysique LA, Heaton RK, Mayo NE. (2016). Identifying neurocognitive decline at 36 months among HIV-positive participants in the CHARTER Cohort using group-based trajectory analysis. PloS One, 11(5), e0155766. PMID: 27191850 | | Ma Q, Vaida F, Wong J, Sanders CA, Kao YT, Croteau D, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, Morgello S, Simpson DM, Heaton RK, Grant I, Letendre SL. (2016). Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients. Journal of Neurovirology, 22(2), 170-178. PMID: 26407716 PMCID: PMC4783211 | | Fazeli PL, Moore DJ, Franklin DR, Umlauf A, Heaton RK, Collier AC, Marra CM, Clifford DB, Gelman BB, Sacktor NC, Morgello S, Simpson DM, McCutchan JA, Grant I, Letendre S L, for the CHARTER Group. (2016). Lower CSF Aβ is associated with HAND in HIV-infected adults with a family history of dementia. Current HIV Research, 14(4), 324-330. PMID: 26673902 PMCID: PMC4916008 | | Hammond ER, Crum RM, Treisman GJ, Mehta SH, Clifford DB, Ellis RJ, Gelman BB, Grant I, Letendre SL, Marra CM, Morgello S, Simpson DM, Mcarthur JC, and the CHARTER Group. (2016). Persistent CSF but not plasma HIV RNA is associated with increased risk of new-onset moderate-to-severe depressive symptoms: A prospective cohort study. Journal of Neurovirology, 22(4), 479-487. PMID: 26727907 PMCID: PMC4925276 | | Marquine MJ, Montoya JL, Umlauf A, Fazeli PL, Gouaux B, Heaton RK, Ellis RJ, Letendre SL, Grant I, Moore DJ, and the HNRP Group. (2016). The Veterans Aging Cohort Study (VACS) Index and neurocognitive change: A longitudinal study. Clinical Infectious Diseases : An Official Publication of The Infectious Diseases Society of America, 63(5), 694-702. PMID: 27199461 PMCID: PMC4981756 | | Sattler F, He J, Letendre S, Wilson C, Sanders C, Heaton R, Ellis R, Franklin D, Aldrovandi G, Marra CM, Clifford D, Morgello S, Grant I, Mccutchan JA, for the CHARTER Group. (2015). Abdominal obesity contributes to neurocognitive impairment in HIV infected patients with increased inflammation and immune activation. Journal of Acquired Immune Deficiency Syndromes, 68(3), 281-288. PMID: 25469522 PMCID: PMC4551458 | | Clifford DB, Vaida F, Kao Y, Franklin DR, Letendre SL, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, Grant I, Heaton RK, for the CHARTER Group. (2015). Absence of neurocognitive effect of Hepatitis C infection in HIV-coinfected people. Neurology, 84(3), 241-250. PMID: 25503616 PMCID: PMC4335996 | | Anderson A, Fennema-Notestine C, Umlauf A, Taylor MJ, Clifford DB, Marra CM, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Simpson DM, Morgello S, Grant I, Letendre SL. (2015). CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease. Journal of Neurovirology, 21(5), 559-567. PMID: 26069183 | | Suh H, Lo Y, Choi N, Letendre S, Lee SC. (2015). Insulin-like growth factors and related proteins in plasma and cerebrospinal fluids of HIV-positive individuals. Journal of Neuroinflammation, 12(1), 72. PMID: 25890304 PMCID: PMC4407382 | | Hulgan T, Samuels DC, Bush W, Ellis RJ, Letendre SL, Heaton RK, Franklin DR, Straub P, Murdock DG, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, McCutchan JA, Morgello S, Simpson DM, Grant I, Kallianpur AR, the CHARTER Group. (2015). Mitochondrial DNA haplogroups and neurocognitive impairment during HIV infection. Clinical Infectious Diseases : An Official Publication of The Infectious Diseases Society of America, 61(9), 1476-1484. PMID: 26129753 PMCID: PMC4599391 | | Heaton RK, Franklin DR, Deutsch R, Letendre S, Ellis RJ, Casaletto K, Marquine MJ, Woods SP, Vaida F, Atkinson JH, Marcotte TD, McCutchan JA, Collier AC, Marra CM, Clifford DB, Gelman BB, Sacktor N, Morgello S, Simpson DM, Abramson I, Gamst AC, Fennema-Notestine C, Smith DM, Grant I. (2015). Neurocognitive change in the era of HIV combination antiretroviral therapy: The longitudinal CHARTER Study. Clinical Infectious Diseases : An Official Publication of The Infectious Diseases Society of America, 60(3), 473-480. PMID: 25362201 PMCID: PMC4303775 | | Malvar J, Vaida F, Sanders CF, Atkinson JH, Bohannon W, Keltner J, Robinson-Papp J, Simpson DM, Marra CM, Clifford DB, Gelman B, Fan J, Grant I, Ellis RJ, for the CHARTER Group. (2015). Predictors of new onset distal neuropathic pain in HIV-infected individuals in the era of combination antiretroviral therapy. Pain, 156(4), 731-739. PMID: 25659067 PMCID: PMC4374054 | | Hobkirk AL, Starosta AJ, De Leo JA, Marra CM, Heaton RK, Earleywine M. (2015). Psychometric validation of the BDI-II among HIV-positive CHARTER study participants. Psychological Assessment, 27(2), 457-466. PMID: 25419643 PMCID: PMC4442079 | | Grant I, Franklin DR, Deutsch R, Woods SP, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Smith DM, Heaton RK, for the CHARTER Group. (2014). Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline. Neurology, 82(23), 2055-2062. PMID: 24814848 PMCID: PMC4118496 | | Archibald SL, McCutchan JA, Sanders C, Wolfson T, Jernigan TL, Ellis RJ, Ances BM, Collier AC, McArthur JC, Morgello S, Simpson DM, Marra C, Gelman BB, Clifford DB, Grant I, Fennema-Notestine C; for the CHARTER Group. (2014). Brain morphometric correlates of metabolic variables in HIV: the CHARTER study. Journal of NeuroVirology, 20(6), 603-611. PMID: 25227933 PMCID: PMC4268263 | | | Biswas B, Spitznagel E, Collier A, Gelman B, McArthur J, Morgello S, McCutchan JA, Clifford DB
and the CHARTER Group. (2014). Characterizing HIV medication adherence for virologic successes among individuals
living with HIV/AIDS: Lessons from the CNS HIV Antiretroviral Therapy Effects Research. Journal of HIV/AIDS & Social Services, 13(1), 8-25. PMCID: PMC3963153 | | Kallianpur AR, Jia P, Ellis RJ, Zhao Z, Bloss C, Wen W, Marra CM, Hulgan T, Simpson DM, Morgello S, McArthur JC, Clifford DB, Collier AC, Gelman BB, McCutchan JA, Franklin D, Samuels DC, Rosario D, Holzinger E, Murdock DG, Letendre S, Grant I. (2014). Genetic variation in iron metabolism is associated with neuropathic pain and pain severity in HIV-infected patients on antiretroviral therapy. PloS One, 9(8), e103123. PMID: 25144566 PMCID: PMC4140681 | | Keltner JR, Fennema-Notestine C, Vaida F, Wang D, Franklin DR, Dworkin RH, Sanders C, McCutchan JA, Archibald SL, Miller DJ, Kesidis G, Cushman C, Kim SM, Abramson I, Taylor MJ, Theilmann RJ, Julaton MD, Notestine RJ, Corkran S, Cherner M, Duarte NA, Alexander T, Robinson-Papp J, Gelman BB, Simpson DM, Collier AC, Marra CM, Morgello S, Brown G, Grant I, Atkinson JH, Jernigan TL, Ellis RJ. (2014). HIV-associated distal neuropathic pain is associated with smaller total cerebral cortical gray matter. Journal of Neurovirology, 20(3), 209-218. PMID: 24549970 PMCID: PMC4040150 | | Hammond ER, Crum RM, Treisman GJ, Mehta SH, Marra CM, Clifford DB, Morgello S, Simpson DM, Gelman BB, Ellis RJ, Grant I, Letendre SL, McArthur JC. (2014). The Cerebrospinal Fluid HIV Risk Score for assessing central nervous system activity in persons with HIV. American Journal of Epidemiology, 180(3), 297-307. PMID: 24966216 PMCID: PMC4108039 | | Ferrara M, Umlauf A, Sanders C, Meyer JM, McCutchan JA, Duarte N, Atkinson JH, Grant I, Ellis RJ, and the CHARTER Group. (2014). The concomitant use of second-generation antipsychotics and long-term antiretroviral therapy may be associated with increased cardiovascular risk. Psychiatry Research, 218(1-2), 201-208. PMID: 24794030 PMCID: PMC4082695 | | Marquine MJ, Umlauf A, Rooney A, Fazeli P, Gouaux B, Woods SP, Letendre SL, Ellis RJ, Grant I, Moore DJ and the HNRP Group. (2014). The Veterans Aging Cohort Study (VACS) Index is associated with concurrent risk for neurocognitive impairment. Journal of Acquired Immune Deficiency Syndromes, 65(2), 190-197. PMID: 24442225 PMCID: PMC3907119 | | Bandaru VVR, Mielke MM, Sacktor N, McArthur JC, Grant I, Letendre S, Chang L, Wojna V, Pardo C, Calabresi P, Munsaka S, Haughey NJ. (2013). A lipid storage-like disorder contributes to cognitive decline in HIV-infected subjects. Neurology, 81(17), 1492-1499. PMID: 24027056 PMCID: PMC3888167 | | Morgan EE, Woods SP, Letendre SL, Franklin DR, Bloss C, Goate A, Heaton RK, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Ellis RJ, Abramson I, Gamst A, Fennema-Notestine C, Smith DM, Grant I, Vaida F, Clifford DB; The CNS HIV Antiretroviral Therapy Effects Research (CHARTER) Group. (2013). Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders. Journal of NeuroVirology, 19(2), 150-156. PMID: 23408335 PMCID: PMC3668779 | | Sakamoto M, Marcotte TD, Umlauf A, Franklin D, Heaton RK, Ellis RJ, Letendre S, Alexander T, McCutchan JA, Morgan EE, Woods SP, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson D, Grant I. (2013). Concurrent classification accuracy of the HIV Dementia Scale for HIV-associated neurocognitive disorders in the CHARTER Cohort. Journal of Acquired Immune Deficiency Syndromes, 62(1), 36-42. PMID: 23111573 PMCID: PMC3529802 | | Croteau D, Rossi SS, Best BM, Capparelli E, Ellis RJ, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur J, McCutchan JA, Morgello S, Simpson DM, Grant I, Letendre S. (2013). Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentration. The Journal of Antimicrobial Chemotherapy, 68(3), 684-689. PMID: 23143899 PMCID: PMC3566670 | | Burdo TH, Weiffenbach A, Woods SP, Letendre S, Ellis RJ, Williams KC. (2013). Elevated SCD163 in plasma but not csf is a marker of neurocognitive impairment in HIV infection. AIDS (London, England), 27(9), 1387-1395. PMID: 23435298 PMCID: PMC3844286 | | Nguyen A, Rossi S, Croteau D, Best BM, Clifford D, Collier AC, Gelman B, Marra C, McArthur J, McCutchan JA, Morgello S, Simpson D, Ellis RJ, Grant I, Capparelli E, Letendre S, on behalf of the CHARTER Group. (2013). Etravirine in CSF is highly protein bound. The Journal of Antimicrobial Chemotherapy, 68(5), 1161-1168. PMID: 23335197 PMCID: PMC3625433 | | Fennema-Notestine C, Ellis RJ, Archibald SL, Jernigan TL, Letendre SL, Notestine RJ, Taylor MJ, Theilmann RJ, Julaton MD, Croteau DJ, Wolfson T, Heaton RK, Gelman BB, Marra C, McArthur JC, McCutchan JA, Morgello S, Simpson DM, Grant I, for the CHARTER Group. (2013). Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infection. Journal of NeuroVirology, 19(4), 393-401. PMID: 23838849 PMCID: PMC3776609 | | Marra CM, Deutsch R, Collier AC, Morgello S, Letendre S, Clifford D, Gelman B, McArthur J, McCutchan JA, Simpson DM, Duarte NA, Heaton RK, Grant I. (2013). Neurocognitive impairment in HIV-infected individuals with previous syphilis. International Journal of STD & AIDS, 24(5), 351-355. PMID: 23970701 PMCID: PMC4560461 | | Andrade A, Deutsch R, Celano S, Duarte NA, Marcotte TD, Umlauf A, Atkinson JH, McCutchan JA, Franklin D, Alexander TJ, McArthur J, Marra C, Grant I, Collier AC. (2013). Relationships among neurocognitive status, medication adherence measured by pharmacy refill records, and virologic suppression in HIV-infected persons. Journal of Acquired Immune Deficiency Syndromes, 62(3), 282-92. PMID: 23202813 PMCID: PMC3906725 | | Kamat A, Misra V, Cassol E, Ancuta P, Yan Z, Li C, Morgello S, Gabuzda D. (2012). A plasma biomarker signature of immune activation in HIV patients on antiretroviral therapy. PLoS One, 7(2), e30881. PMID: 22363505 PMCID: PMC3281899 | | Perez-Valero I, Cysique L, Letendre S, Heaton R. (2012). Comments to Garvey et al.: "Low rates of neurocognitive impairment are observed in neuro-asymptomatic HIV-infected subjects on effective antiretroviral therapy". HIV Clinical Trials, 13(5), 296-298. PMID: 23134631 | | Blackstone K, Moore DJ, Franklin Dr, Clifford DB, Collier, AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, Ellis RJ, Atkinson JH, Grant I, Heaton RK, for the CHARTER Group. (2012). Defining neurocognitive impairment in HIV: Deficit scores versus clinical ratings. The Clinical Neuropsychologist, 26(6), 894-908. PMID: 22708483 PMCID: PMC3848322 | | Blackstone K, Moore DJ, Heaton RK, Franklin DR, Woods SP, Clifford DB, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, Rivera-Mindt M, Deutsch R, Ellis RJ, Hampton Atkinson J, Grant I, and the CHARTER Group. (2012). Diagnosing symptomatic HIV-associated neurocognitive disorders: Self-report versus performance-based assessment of everyday functioning. Journal of the International Neuropsychological Society, 18(1), 79-88. PMID: 22114912 PMCID: PMC3882265 | | Choi JY, Hightower GK, Wong JK, Heaton R, Woods S, Grant I, Marcotte TD, Ellis RJ, Letendre SL, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Richman DD, Smith DM, and the CHARTER Group. (2012). Genetic features of cerebrospinal fluid-derived Subtype B HIV-1 Tat. Journal of NeuroVirology, 18(2), 81-90. PMID: 22528397 PMCID: PMC2572198 | | Keltner JR, Vaida F, Ellis RJ, Moeller-Bertram T, Fitzsimmons C, Duarte NA, Robinson-Papp J, Dworkin RH, Clifford DB, McArthur JC, Simpson DM, Collier AC, Marra CM, Atkinson JH, Grant I, and the CHARTER Group. (2012). Health-related quality of life 'Well-Being' in HIV distal neuropathic pain is more strongly associated with depression severity than with pain intensity. Psychosomatics, 53(4), 380-386. PMID: 22748751 PMCID: PMC3389373 | | Hightower GK, Wong JK, Letendre SL, Umlauf AA, Ellis RJ, Ignacio CC, Heaton RK, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Grant I, Little SJ, Richman DD, Pond SLK, Smith DM, and the CHARTER Study Group. (2012). Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment. Virology, 433(2), 498-505. PMID: 22999095 PMCID: PMC3466337 | | Badiee J, Moore DJ, Atkinson JH, Vaida F, Gerard M, Duarte NA, Franklin D, Gouaux B, McCutchan JA, Heaton RK, McArthur J, Morgello S, Simpson D, Collier A, Marra CM, Gelman B, Clifford D, Grant I. (2012). Lifetime suicidal ideation and attempt are common among HIV+ individuals. Journal of Affective Disorders, 136(3), 993-999. PMID: 21784531 PMCID: PMC3222733 | | Best BM, Letendre SL, Koopmans P, Rossi SS, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, McCutchan JA, Morgello S, Simpson DM, Capparelli EV, Ellis RJ, Grant I, and the CHARTER Study Group. (2012). Low CSF concentrations of the nucleotide HIV reverse transcriptase inhibitor, Tenofovir. Journal of AIDS, 59(4), 376-381. PMID: 22217676 PMCID: PMC3299895 | | Croteau D, Best BM, Letendre S, Rossi SS, Ellis RJ, Clifford DB, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Morgello S, Grant I, and the CHARTER Group. (2012). Lower than expected maraviroc concentrations in cerebrospinal fluid exceed the wild-type CCR5-tropic HIV-1 50% inhibitory concentration. AIDS, 26(7), 890-893. PMID: 22313954 PMCID: PMC3454507 | | Holzinger ER, Hulgan T, Ellis RJ, Samuels DC, Ritchie MD, Haas DW, Kallianpur AR, Bloss CS, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, McCutchan JA, Morgello S, Simpson DM, Franklin DR, Rosario D, Selph D, Letendre S, Grant I. (2012). Mitochondrial DNA variation and HIV-associated sensory neuropathy in CHARTER. Journal of Neurovirology, 18(6), 511-520. PMID: 23073667 PMCID: PMC3587171 | | Kamat A, Lyons JL, Misra V, Uno H, Morgello S, Singer EJ, Gabuzda D. (2012). Monocyte activation markers in cerebrospinal fluid associated with impaired neurocognitive testing in advanced HIV infection. Basic and Translational Science, 60(3), 234-243. PMID: 22569268 PMCID: PMC3383928 | | Patton DE, Woods SP, Franklin D, Cattie JE, Heaton RK, Collier AC, Marra C, Clifford D, Gelman B, McArthur J, Morgello S, Simpson D, McCutchan JA, Grant I. (2012). Relationship of Medication Management Test-Revised (MMT-R) performance to neuropsychological functioning and antiretroviral adherence in adults with HIV. AIDS And Behavior, 16(8), 2286-2296. PMID: 22722882 PMCID: PMC3575112 | | McCutchan JA, Marquie-Beck J, Fitzsimons C, Letendre SL, Ellis RJ, Heaton RK, Wolfson T, Rosario D, Alexander TJ, Marra C, Ances BM, Grant I, and the CHARTER Group. (2012). Role of obesity, metabolic variables, and diabetes
in HIV-associated neurocognitive disorder. Neurology, 78(7), 485-492. PMID: 22330412 PMCID: PMC3280051 | | Croteau D, Letendre S, Best BM, Rossi SS, Ellis RJ, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur J, McCutchan JA, Morgello S, Simpson DM, Way L, Capparelli E, Grant I; and the CHARTER Group. (2012). Therapeutic amprenavir concentrations in cerebrospinal fluid. Antimicrobial Agents and Chemotherapy, 56(4), 1985-89. PMID: 22290964 PMCID: PMC3318381 | | Ellis RJ, Badiee J, Vaida F, Letendre S, Heaton RK, Clifford D, Collier AC, Gelman B, McArthur J, Morgello S, McCutchan JA, Grant I, and the CHARTER Group. (2011). CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS (London, England), 25(14), 1747-1751. PMID: 21750419 PMCID: PMC3867631 | | Jernigan TL, Archibald SL, Fennema-Notestine C, Taylor MJ, Theilmann RJ, Julaton MD, Notestine RJ, Wolfson T, Letendre SL, Ellis RJ, Heaton RK, Gamst AC, Franklin DR, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, McCutchan JA, Morgello S, Simpson DM, Grant I, and the CHARTER Group. (2011). Clinical factors related to brain structure in HIV: The CHARTER Study. Journal of NeuroVirology, 17, 248-257. PMID: 21544705 PMCID: PMC3702821 | | Bharti AR, Letendre SL, Wolfson T, Clifford D, Collier AC, Gelman B, McArthur J, Marra C, McCutchan A, Morgello S, Simpson D, Ellis RJ, Grant I, for the CHARTER Group. (2011). Clinical variables identify seronegative HCV co-infection in HIV-infected individuals. Journal of Clinical Virology, 52(4), 328-32. PMID: 21924674 PMCID: PMC3217127 | | Best B, Koopmans P, Letendre S, Capparelli E, Rossi S, Clifford D, Collier A, Gelman B, Mbeo G, McCutchan J, Simpson D, Haubrich R, Ellis R, Grant I, and the CHARTER Group. (2011). Efavirenz concentrations in cerebrospinal fluid exceed wild-type HIV IC50. Journal of Antimicrobial Chemotherapy, 66, 354-357. PMID: 21098541 PMCID: PMC3019085 | | Lin K, Taylor MJ, Heaton RK, Franklin D, Jernigan TL, Fennema-Notestine C, McCutchan A, Atkinson JH, McArthur J, Morgello Simpson D, Collier A, Marra C, Gelman B, Clifford D, Grant I, and the CHARTER Group. (2011). Effects of traumatic brain injury on cognitive functioning and cerebral metabolites in HIV infected individuals. Journal of Clinical and Experimental Neuropsychology, 33, 326-334. PMID: 21229435 PMCID: PMC3062232 | | Moore DJ, Arce M, Moseley S, McCutchan JA, Marquie-Beck J, Franklin DR, Vaida F, Achim C, McArthur J, Morgello S, Simpson DM, Gelman BB, Collier AC, Marra CM, Clifford DB, Heaton RK, Grant I, the CHARTER Group and the HNRC Group. (2011). Family history of dementia predicts worse neuropsychological functioning among HIV infected persons. Journal of Neuropsychiatry and Clinical Neurosciences, 23(3), 316-323. PMID: 21948893 PMCID: PMC3279193 | | Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, Collier AC, Marra CM, Morgello S, Mindt M, Taylor MJ, Marcotte TD, Atkinson JH, Wolfson T, Gelman BB, McArthur JC, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I, the CHARTER Group, and the HNRC Group. (2011). HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: Differences in rates, nature, and predictors. Journal of NeuroVirology, 17(1), 3-16. PMID: 21174240 PMCID: PMC3032197 | | Moore DJ, Letendre SL, Morris S, Umlauf A, Deutsch R, Smith DM, Little S, Rooney A, Franklin DR, Gouaux B, Leblanc S, Rosario D, Fennema-Notestine C, Heaton RK, Ellis RJ, Atkinson JH, Grant I, and the CHARTER Group. (2011). Neurocognitive functioning in acute or early HIV infection. Journal of NeuroVirology, 17(1), 50-57. PMID: 21165782 PMCID: PMC3032208 | | Byrd DA, Fellows RP, Morgello S, Franklin D, Heaton RK, Deutsch R, Atkinson JA, Clifford DB, Collier AC, Marra C, Gelman B, McCutchan JA, Duarte NA, Simpson D, McArthur J, Grant I, and the CHARTER Group. (2011). Neurocognitive impact of substance use in HIV infection. Journal of Acquired Immune Deficiency Syndromes, 58(2), 154-162. PMID: 21725250 PMCID: PMC3183737 | | Cysique LA, Franklin, D, Abramson I, Ellis RJ, Letendre S, Collier A, Clifford D, Gelman B, McArthur J, Morgello S, Simpson D, McCutchan JA, Grant I, Heaton RK, the CHARTER Group, and the HNRC Group. (2011). Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change. Journal of Clinical and Experimental Neuropsychology, 33, 505-522. PMID: 21391011 PMCID: PMC3151558 | | Overton ET, Kauwe JSK, Paul R, Tashima K, Tate DF, Patel P, Carpenter CCJ, Patty D, Brooks JT, Clifford DB. (2011). Performances on the CogState and Standard Neuropsychological Batteries among HIV patients without dementia. AIDS and Behavior, 15(8), 1902-1909. PMID: 21877204 PMCID: PMC3594991 | | Robinson-Papp J, Morgello S, Vaida F, Fitzsimons C, Simpson D, Elliott K, Al-Lozi M, Gelman B, Clifford D, Marra C, McCutchan J, Atkinson J, Dworkin R, Grant I, Ellis R. (2010). Association of self-reported painful symptoms with clinical and neurophysiologic signs in HIV-associated sensory neuropathy. Pain, 151, 732-736. PMID: 20851521 PMCID: PMC2972365 | | Ellis R, Rosario D, Clifford D, McArthur J, Simpson D, Alexander T, Gelman B, Vaida F, Collier A, Marra C, Ances B, Atkinson JH, Dworkin R, Morgello S, Grant I, and the CHARTER Study Group. (2010). Continued high prevalence and adverse
clinical impact of human immunodeficiency
virus–associated sensory neuropathy in the era
of combination antiretroviral therapy: The CHARTER Study. Archives of Neurology, 67(5), 552-558. PMID: 20457954 PMCID: PMC3924778 | | Heaton RK, Clifford DB, Franklin Jr DR, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Rivera-Mindt M, Vigil OR, Taylor MJ, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I, and the CHARTER Group. (2010). HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology, 75(23), 2087-2096. PMID: 21135382 PMCID: PMC2995535 | | McArthur JC, Brew BJ. (2010). HIV-associated neurocognitive disorders: is there a hidden epidemic? AIDS, 24(9), 1367-1370. PMID: 20559041 | | Croteau D, Letendre S, Best BM, Ellis RJ, Breidinger S, Clifford D, Collier A, Gelman B, Marra C, Mbeo G, McCutchan A, Morgello S, Simpson D, Way L, Vaida F, Ueland S, Capparelli E, Grant I; and the CHARTER Group. (2010). Total Raltegravir concentrations in cerebrospinal fluid exceed the 50% inhibitory concentration for wild-type HIV-1. Antimicrobial Agents and Chemotherapy, 54, 5156-5160. PMID: 20876368 PMCID: PMC2981289 | | Best BM, Letendre SL, Brigid E, Clifford DB, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Simpson DM, Ellis R, Capparelli EV, Grant I, and the CHARTER Group. (2009). Low atazanavir concentrations in cerebrospinal fluid. AIDS, 23(1), 83-87. PMID: 19050389 PMCID: PMC2642983 | | Gongvatana A, Schweinsburg BC, Taylor MJ, Theilmann RJ, Letendre SL, Alhassoon OM, Jacobus J, Woods SP, Jernigan TL, Ellis RJ, Frank LR, Grant I, and the CHARTER Group. (2009). White matter tract injury and cognitive impairment in HIV-infected individuals. Journal of NeuroVirology, 15(2), 187-195. PMID: 19306228 PMCID: PMC3066173 | | | Letendre S, McCutchan JA, Ellis RJ. (2008). Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. Neurologic complications of HIV disease and their treatment. Topics in HIV Medicine, 16(1), 15-22. PMID: 18441379 | | Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Morgello S, Simpson D, Grant I, Ellis RJ, and the CHARTER Group. (2008). Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Archives of Neurology, 65(1), 65-70. PMID: 18195140 PMCID: PMC2763187 | | Letendre S, Marquie-Beck J, Ellis RJ, Woods SP, Best B, Clifford DB, Collier AC, Gelman BB, Marra C, McArthur JC, McCutchan JA, Morgello S, Simpson D, Alexander TJ, Durelle J, Heaton R, Grant I, and the CHARTER Group. (2007). The role of cohort studies in drug development: clinical evidence of antiviral activity of serotonin reuptake inhibitors and HMG-CoA reductase inhibitors in the central nervous system. Journal of Neuroimmune Pharmacology, 2, 120-127. PMID: 18040835 |
|